FINWIRES · TerminalLIVE
FINWIRES

WECエナジー、第1四半期の電力販売量は増加、ガス販売量は減少

By

-- WECエナジー(WEC)は火曜日、第1四半期決算を発表し、ウィスコンシン州における小売電力販売量が前年同期比1.6ギガワット時増加したことを明らかにした。 同社によると、鉱業部門を除く小売電力販売量は1.1%増加した。 WECエナジーは、商業・産業顧客からの需要増に牽引され、販売量は前年同期比2.7%増加したと述べた。商業・産業部門の電力販売量は合計で4%増加した。住宅部門の需要はほぼ横ばいで、0.2%の小幅増加にとどまった。 一方、住宅向けガス販売量は前年同期比4%減少したが、商業・産業部門の合計販売量は4.7%増加した。小売天然ガス販売量は全体で4.3%減少し、天候調整後ベースでは2.5%減少した。 WECエナジーによると、発電部門を除く輸送部門のガス販売量は2%減少し、発電部門を除くガス販売量全体は3.5%減少した。 同社によると、第1四半期の総電力販売量は前年同期の10.62テラワット時(TWh)から3.3%減の10.28TWhとなった。 同社は、2026年の総電力小売販売量が約1.5%増加すると予測しており、特に商業・産業部門では5.1%の大幅な伸びが見込まれる。 当四半期の電力小売販売量は前年同期比1.6%増の9TWhとなった。商業・産業向け販売量は4%増の2.97TWh、小規模商業・産業向け需要は0.7%増の3.21TWhだった。住宅向け販売量は概ね横ばいで、0.2%増の2.80TWhだった。

Price: $116.47, Change: $+0.03, Percent Change: +0.03%

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE